Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
DA Davidson Reiterates Buy Rating on F.N.B. Corporation (FNB)
-
Citizens Financial Group (CFG) PT Raised to $55 at DA Davidson
-
Morgan Stanley Reiterates Equalweight Rating on Sarepta Therapeutics (SRPT)
-
-
-
-
-
-
-
Raymond James Reiterates Market Perform Rating on Bristol-Myers Squibb Co. (BMY)
-
-
-
-
-
-
-
Goldman Sachs Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Ambarella (AMBA)
-
-
-
-
-
-
-
Elevance (ELV) PT Lowered to $360 at Guggenheim
-
-
-
-
-
-
-
Rosenblatt Starts SentinelOne Inc (S) at Buy
-
-
-
-
-
424,420 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.
